Keratosis Pilaris Research

I have read the Keratosis Pilaris Research Petition to American Academy of Dermatology; Charterhouse Therapeutics; Connetics; Enhance Biotech, Inc.; SoleRx, LLC; Molecular SkinCare Limited; Neutrogena; Medicis Pharmaceutical Corporation; Miravant Medical Technologies; Serono; bio.com; Barrier Therapeutics; AGI Dermatics; Central Dermatology; Bioglan Pharma; DermaCo; Bradley Pharmaceuticals, Inc.; Harvard Skin Disease Research Center; St. John's Institute of Dermatology, Cutaneous Biology Research; Bioinformatics Center, University of Singapore; Cambridge Healthtech Institute; Department of Dermatology, New York University; Institute of Biomedical Engineering, University of Toronto; Department of Dermatology, University of British Columbia; Department of Dermatology, University of California at Davis; Department of Dermatology, University of California, San Francisco; Department of Dermatology, University of Pittsburgh; Department of Dermatology, University of Colorado at Denver; Department of Dermatology, University of Erlangen, Germany; Department of Dermatology, University of Illinois; Department of Dermatology, University of Indiana; Department of Dermatology, University of Iowa; Department of Dermatology, University of Michigan; Department of Dermatology, University of North Carolina; Department of Dermatology, University of Virginia; Department of Dermatology, University of Wales College of Medicine; Department of Dermatology, Washington University in Saint Louis; Washington University Institute for Biomedical Computing; Department of Dermatology, Yale University; Department of Dermatology, University of Edinburgh; British Association of Dermatologists; Department of Dermatology, Baylor College of Medicine, Houston; Department of Dermatology, University of Pennsylvania; Department of Dermatology, University of Connecticut; Department of Dermatology, University of Miami; Department of Dermatology, University of Kansas; Department of Dermatology, University of Wales College of Medicine; Department of Dermatology, University of Newcastle upon Tyne; Department of Dermatology, Tulane University School of Medicine; Department of Dermatology, University of Cincinnati; Department of Dermatology, Osaka University; Department of Dermatology, Northwestern University Feinberg School of Medicine; Department of Dermatology, Oregon Health Sciences University; Department of Dermatology, University of Texas Southwest Medical Center at Dallas; Department of Dermatology, Medical College of Wisconsin; Department of Dermatology, Boston University Medical Center; Department of Dermatology, Mt. Sinai School of Medicine; Department of Dermatology, University of California at Irvine; Department of Dermatology, University of Arkansas; Department of Dermatology, Stanford University School of Medicine; Department of Dermatology, Mayo Clinic; Department of Dermatology, Emory University; Department of Dermatology, University of Minnesota; Department of Dermatology, New York Weill Cornell Medical College of Cornell University and New York Presbyterian Hospital, Belfer Gene Therapy Core Facility; Department of Dermatology, David Geffen School of Medicine at the University of California at Los Angeles, and I hereby sign the petition:

Eligible signatories:	anybody
Name: (required)
Email Address: (required)
Comments: (optional)
Please note: All information you provide on this petition signing form will be public on the petition signatures page, except your email address, for which privacy is set here:
Email Address Privacy Option: (choose one)	Private  Available to Petition Author  Public
Explanation of Email Address Privacy Options: - "Private" means your email address is stored in a secure private location, for signature validation only. - "Available to Petition Author" means your email address will not be available to the public, but will be available to the petition author, as well as being stored in a secure private location for signature validation. - "Public" means anyone viewing the signature pages on the Web for this petition can get your email address and send you email.

View Signatures Without Signing

The Keratosis Pilaris Research Petition to American Academy of Dermatology; Charterhouse Therapeutics; Connetics; Enhance Biotech, Inc.; SoleRx, LLC; Molecular SkinCare Limited; Neutrogena; Medicis Pharmaceutical Corporation; Miravant Medical Technologies; Serono; bio.com; Barrier Therapeutics; AGI Dermatics; Central Dermatology; Bioglan Pharma; DermaCo; Bradley Pharmaceuticals, Inc.; Harvard Skin Disease Research Center; St. John's Institute of Dermatology, Cutaneous Biology Research; Bioinformatics Center, University of Singapore; Cambridge Healthtech Institute; Department of Dermatology, New York University; Institute of Biomedical Engineering, University of Toronto; Department of Dermatology, University of British Columbia; Department of Dermatology, University of California at Davis; Department of Dermatology, University of California, San Francisco; Department of Dermatology, University of Pittsburgh; Department of Dermatology, University of Colorado at Denver; Department of Dermatology, University of Erlangen, Germany; Department of Dermatology, University of Illinois; Department of Dermatology, University of Indiana; Department of Dermatology, University of Iowa; Department of Dermatology, University of Michigan; Department of Dermatology, University of North Carolina; Department of Dermatology, University of Virginia; Department of Dermatology, University of Wales College of Medicine; Department of Dermatology, Washington University in Saint Louis; Washington University Institute for Biomedical Computing; Department of Dermatology, Yale University; Department of Dermatology, University of Edinburgh; British Association of Dermatologists; Department of Dermatology, Baylor College of Medicine, Houston; Department of Dermatology, University of Pennsylvania; Department of Dermatology, University of Connecticut; Department of Dermatology, University of Miami; Department of Dermatology, University of Kansas; Department of Dermatology, University of Wales College of Medicine; Department of Dermatology, University of Newcastle upon Tyne; Department of Dermatology, Tulane University School of Medicine; Department of Dermatology, University of Cincinnati; Department of Dermatology, Osaka University; Department of Dermatology, Northwestern University Feinberg School of Medicine; Department of Dermatology, Oregon Health Sciences University; Department of Dermatology, University of Texas Southwest Medical Center at Dallas; Department of Dermatology, Medical College of Wisconsin; Department of Dermatology, Boston University Medical Center; Department of Dermatology, Mt. Sinai School of Medicine; Department of Dermatology, University of California at Irvine; Department of Dermatology, University of Arkansas; Department of Dermatology, Stanford University School of Medicine; Department of Dermatology, Mayo Clinic; Department of Dermatology, Emory University; Department of Dermatology, University of Minnesota; Department of Dermatology, New York Weill Cornell Medical College of Cornell University and New York Presbyterian Hospital, Belfer Gene Therapy Core Facility; Department of Dermatology, David Geffen School of Medicine at the University of California at Los Angeles was created by and written by Michael Langdon.   The petition is hosted here at www.PetitionOnline.com as a public service. There is no endorsement of this petition, express or implied, by Artifice, Inc. or our sponsors.   For technical support please use our simple Petition Help form.